A framework of the recombination pathway for coronaviruses

FHS
June 16, 2023
10:39 am

Researchers explored the different aspects of the coronavirus recombination pathway.

Chiesi bets $160M on Gossamer Bio’s make-or-break late-stage PAH drug

Gossamer Bio has lined up a partner to foot the development and commercialization bill for its make-or-break late-stage drug, expanding Phase 3 plans and paving

May 7, 2024

MAPS Unveils Improved Fiscal Sponsorship Program, Empowering Innovators in the Psychedelic Movement | Psychedelic Invest

To date, MAPS has supported nearly 70 organizations worldwide to advance charitable projects in the psychedelic movement Currently, MAPS serves as a fiscal sponsor for

January 17, 2024

Generic makers fall short when providing access to low- and middle-income countries, analysis finds

A handful of the largest purveyors of generic medicines have made only halting progress to ensure their drugs are accessible for patients in low- and

September 29, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.